Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia

Clinical trial NCT07247279 · RECRUITING

Trial details

NCT number: NCT07247279
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Rare Diseases Generalized Myasthenia Gravis (gMG)

Start date: 2025-12-23
Primary completion: 2029-12-31
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.